China Market Update: WuXi Apptec Doubles Profit, Childcare Stimulus Launched
Asian equities were mixed overnight as Mainland China's STAR Market and Thailand outperformed, while Vietnam and Pakistan underperformed.
Trade representatives from the US and China completed two days of talks that had the expressed purpose of extending the August 1st deadline for a trade deal. Most analysts are saying that a 90-day extension is likely. The global economy has weathered the tariffs better than expected so far, though it is important to remember the level of exemptions granted to key product areas, especially for China. We need a deal, but the negotiators are taking their time, which will hopefully result in the best possible outcome. Fingers crossed!
Recent outperformers were sold off today, except for health care. Viral Labubu doll-maker Pop Mart was net sold by Mainland investors via Southbound Stock Connect, who likely took profits in the name. Meanwhile, insurance companies were also sold off following a strong rally yesterday on lower interest rate guidance for insurance contracts. Internet stocks were mostly lower as we head into earnings season next month. However, some price targets for video platform Kuaishou were raised, though the stock was down overnight.
WuXi Apptec indicated that its net profit for the first half 2025 more than doubled. The stock was up +11.25% in Hong Kong overnight. WuXi Apptec has seen significant tailwinds this year, along with its co-named peer WuXi Biologics. These include the removal of an extreme geopolitical overhang on Wuxi Biologics and Apptec: the proposed BIOSECURE Act, which would have barred it from working with US entities receiving federal medicare and medicaid dollars. It is estimated that one-third of all the drugs on the US market today passed through China-based contract research labs, such as WuXi Apptec and Biologics. They are based in China but have facilities all over the world, including in the United States.
China committed new capital to increasing the birth rate. The government will now allocate RMB 3,600 annually for families with children under three. Related stocks cheered the news. Does this count as additional stimulus for consumption? Indirectly, yes. The lack of a social safety net and deflation are the primary reasons China's consumers hesitate to increase spending significantly.
New Content
Read our latest article:
KraneShares KOID ETF: Humanoid Robot Rings Nasdaq Opening Bell
Please click here to read
Chart1
Chart2
Chart3
Chart4
Chart5
Chart6
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 minutes ago
- Yahoo
Tesla's China Sales Slide Again -- And It's Not Just About Competition
Tesla (NASDAQ:TSLA) just reported a July shipment figure of 67,886 vehicles from its Shanghai plantdown 8.4% from the same time last year. That marks the sixth monthly decline out of seven in 2025. Competition is heating up fast in China, with local players like BYD and Xiaomi coming in strong. Xiaomi's YU7 SUV is now positioned to go head-to-head with Tesla's Model Y. And with ongoing trade tensions adding to the uncertainty, even Tesla's once-dominant China factory isn't immune to pressure. That said, EV and hybrid sales in China aren't slowing downquite the opposite. The market grew 25% year-over-year in July to 1.18 million units. Tesla, however, hasn't kept pace. The company's relatively narrow product range in China could be a factor, though that may soon change. A longer, six-seat version of the Model Y is reportedly on the way, giving Tesla a shot at expanding its addressable market. Whether it's enough to reignite local demand remains to be seenbut it's a signal they're not sitting still. Zooming out, Tesla's global story carries even more complexity. From the U.S. to Europe, sales momentum has been under pressure, and some analysts suggest Elon Musk's public commentary could be influencing consumer behavior. As market sentiment shifts and competition stiffens, Tesla's next movesin product, positioning, and public perceptioncould be pivotal. Investors betting on a rebound will want to see more than just a new seat configuration. This article first appeared on GuruFocus.
Yahoo
2 minutes ago
- Yahoo
Apple Posts Strongest Growth Since 2021 on iPhone Sales
Apple (AAPL, Financials) beat Wall Street estimates for the June quarter as revenue jumped 10% to $94.04 billion, its fastest growth since December 2021. Earnings rose to $1.57 a share from $1.40 a year earlier. iPhone sales climbed 13% to $44.58 billion, driven by strong demand for the iPhone 16. Mac revenue grew nearly 15% to $8.05 billion; services revenue rose 13% to $27.42 billion; China sales gained 4% to $15.37 billion, helped by subsidies. CEO Tim Cook said Apple will significantly grow AI investment and remains open to acquisitions. The company sees mid? to high?single?digit revenue growth in the September quarter, with gross margins of 46% to 47%. This article first appeared on GuruFocus. Sign in to access your portfolio
Forbes
2 minutes ago
- Forbes
200 Best Under A Billion 2025
Illustration by Terri Po for Forbes Asia W ith trade tensions looming over the Asia-Pacific region, long considered the world's economic engine, growth is predicted to continue to slow, according to the International Monetary Fund. Despite these challenges, our annual Best Under A Billion list—featuring 200 small and midsized publicly traded companies with sales above $10 million and below $1 billion—showcases businesses that remained resilient over the past year and, in many cases, thrived. The buoyant financial services sector propelled 18 companies onto the list, more than double from the eight that appeared last year. The beauty industry continues to shine, with 13 companies, mostly South Korean, making the cut this year. Other companies in the region have benefited from the gathering momentum in the segments in which they operate, such as renewable energy, electric vehicles and data centers. In total, 69 companies returned to the 2025 list from the previous year, including India's Triveni Turbine, We've highlighted eight companies that reflects some of the trends mentioned above: Already the largest data center operator in Indonesia with 119 megawatts (MW) of installed capacity, DCI Indonesia expects to add another 9MW when its newest data center in Surabaya comes online later this year. In 2024, revenue rose 39% to 1.8 trillion rupiah ($114 million) while net profit jumped 55% to 796 billion rupiah. DCI Indonesia is the country's most expensive stock, trading at 150,700 rupiah a share in early July, a roughly 35,780% increase since its 2021 listing. Taipei-based solar power and battery storage systems company HD Renewable Energy posted a record NT$10 billion ($310 million) in revenue in 2024, up 73% from a year earlier, on growing demand for green energy. Next up is expanding in markets overseas with joint ventures in the Philippines, Japan and Australia, where it recently spent NT$290 million to buy the development rights to 795MW of energy-storage projects in New South Wales, Victoria and Queensland. iFast Buoyed by the rising tide of wealth in Asia, Singapore-based wealth management platform iFast posted a nearly 50% increase in revenue to S$383 million ($288 million) in 2024, while net profit surged 136% to S$66.6 million. The fintech also got a boost from the improving performance of its U.K. digital bank iFAST Global Bank (formerly BFC Bank), acquired in 2022, which cut its losses by half to $4.4 million last year. At the end of June, iFast had a record S$27 billion in assets under administration, and aims to reach S$100 billion by 2030. IPD Group Australia-based IPD Group says work for power-guzzling data centers—including the design and supply of electrical systems as well as cooling controls—made up 12% of sales in the year ended June 2024, helping its top line surge 28% to A$290 million ($190 million). The electrical products distributor and services provider has lately switched gears to sustainable electrical infrastructure, which includes installing EV chargers in major Australian cities. . KPI Green Energy India's booming market for green power fueled a 70% increase in KPI Green Energy's sales to 17.6 billion rupees ($205 million) in the year ended March, while net profit doubled to 3.2 billion rupees. The Surat-based company, which builds and operates solar and hybrid power plants in its home state of Gujarat, says it aims to install over 10 gigawatts of capacity (up from 950 megawatts currently) by 2030, helped by India's 500GW renewable energy target. KPI also leases out parcels from its 2,400-hectare land bank for solar power projects. PharmaResearch Gangneung, South Korea-based PharmaResearch is best known for its flagship skincare treatment Rejuran, derived from salmon DNA. With sales across Asia-Pacific, the U.S. and Europe, the company saw revenue jump 34% to over 350 billion won ($257 million), while net profit rose by a fifth to 92 billion won, in 2024. Besides cosmetics, the company makes prescription and over-the-counter drugs, including an injectable for knee pain. Shenzhen Envicool Technology Shenzhen Envicool Technology, which makes cooling equipment and systems for vehicles, homes and industrial use, saw revenue and net profit each increase by 30% to 4.6 billion yuan ($634 million) and 452 million yuan, respectively. In June, the company teamed up with Malaysia-based KJTS Group to develop energy-efficient cooling technology for data centers springing up across Southeast Asia. Silicon2 K-beauty's global popularity helped double sales at South Korea-based cosmetics distributor Silicon2 to 692 billion won ($507 million) last year and triple net profit to 120 billion won. Founder Kim Sung-woon started the company in 2002 as a distributor of semiconductor components, then pivoted to makeup and skincare a decade later, betting on a beauty boom. In addition to its e-commerce platform the company has opened stores in France, Indonesia, the U.K. and the U.S. in the past two years. Methodology: This list features companies with a track record of long-term sustainable performance across a variety of metrics. These 200 companies were selected from a universe of more than 19,000 publicly traded companies in the Asia-Pacific region with annual sales above $10 million and below $1 billion. The companies on this unranked list were selected based on a composite score using measures such as debt, sales and earnings-per-share growth over both the most recent fiscal one- and three-year periods, and the strongest one- and five-year average return on equity. Aside from quantitative criteria, qualitative screens were applied, such as excluding companies with serious governance issues, questionable accounting practices, environmental concerns, management problems or legal troubles in recent years. State-controlled entities and subsidiaries of larger companies were also excluded. The criteria sought to ensure a geographical diversity of companies from across the region. The list uses annual results based on the latest publicly available figures as of July 7, 2025. Stock prices on the same date were used to compute market value. Reporting by Vaishalli Chandra, John Kang, Zinnia Lee, Phisanu Phromchanya, Ian Sayson, Catherine Wang and Yue Wang.
